← Back to Search

Corticosteroid

Treatment of Early Nasal Polyposis With Topical Triamcinolone

Phase 1 & 2
Waitlist Available
Research Sponsored by Steward St. Elizabeth's Medical Center of Boston, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks, 6 weeks, 12 weeks were not collected from any participant.
Awards & highlights
All Individual Drugs Already Approved
Approved for 10 Other Conditions

Summary

The purpose of this study is to compare the effectiveness of intranasal Triamcinolone delivered through a bio-absorbable nasal dressing verses oral steroids and a saline soaked dressing, in the treatment and prevention of early nasal polyposis.

Eligible Conditions
  • Prophylaxis of Nasal Polyps
  • Nasal Polyps

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks, 6 weeks, 12 weeks were not collected from any participant.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks, 6 weeks, 12 weeks were not collected from any participant. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Nasal Endoscopic Exam Findings .

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: TriamcinoloneExperimental Treatment1 Intervention
Triamcinolone soaked nasopore dressing
Group II: Control GroupPlacebo Group1 Intervention
Saline soaked sponge
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Triamcinolone
FDA approved

Find a Location

Who is running the clinical trial?

Steward St. Elizabeth's Medical Center of Boston, Inc.Lead Sponsor
25 Previous Clinical Trials
5,750 Total Patients Enrolled
Peter Catalano, MDStudy DirectorSteward St. Elizabeth's Medical Center of Boston, Inc.
5 Previous Clinical Trials
438 Total Patients Enrolled
~0 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top